Dr Reddy’s Laboratories failed to cheer the market despite June quarter net profit doubling. Analysts see concern over the US business and pressure on operating performance as key drags. These concerns have prompted traders to build bearish bets on the stock. Chandan Taparia, derivative analyst at Motilal Oswal, said the weakness could continue and the stock could drift down to Rs 3,950.
Govt prioritising lower denomination notes and digital transactions: Sitharaman
Union Finance Minister Nirmala Sitharaman emphasized the government’s focus on promoting lower denomination currency and increasing digital transaction awareness. With the Rs 2000 note nearly
May 31, 2025